SYPEQIA
Dead / Abandoned — Abandoned — no statement of use filed (as of 05 Jun 2023)
What this means for you
This application is over — abandoned 05 Jun 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90480783
- Mark type
- Stylized text
- Filed
- 21 Jan 2021
- Published for opposition
- 07 Sept 2021
- Abandoned
- 05 Jun 2023
- Attorney of record
- Frances M. Jagla
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer, autoimmune disorders, inflammatory disorders and treatment and prevention of graft/host disorder
- Class 044 — Medical, beauty and agricultural services: Providing healthcare information
Owner
- CTI Biopharma Corp., Seattle, WA, US
- CTI Biopharma Corp., Seattle, WA, US
Prosecution history
- 05 Jun 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 05 Jun 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 29 Oct 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Oct 2022 — SOU EXTENSION 2 GRANTED
- 27 Oct 2022 — SOU EXTENSION 2 FILED
- 27 Oct 2022 — SOU TEAS EXTENSION RECEIVED
- 30 Apr 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Apr 2022 — SOU EXTENSION 1 GRANTED
- 28 Apr 2022 — SOU EXTENSION 1 FILED
- 28 Apr 2022 — SOU TEAS EXTENSION RECEIVED
- 02 Nov 2021 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 07 Sept 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Sept 2021 — PUBLISHED FOR OPPOSITION
- 18 Aug 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 04 Aug 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER